Among the mRNAs we identified, six (CTGF, MCP-1, PAI-1, ACE, CDH1 and CDH2) showed significant difference when the DNI and DNII groups were compared, suggesting these mRNAs might be involved in the development of DN and could hold promise in discriminating different stages of DN. The gene discussed is CCL2; the disease is liver dysplastic nodule.